Nerve regeneration tech targets Alzheimer’s and Nasdaq
Longevity Technology,
NervGen readies for NASDAQ listing and clinical trials of lead compound for nerve regeneration in 2021. With a unique nerve…
NervGen readies for NASDAQ listing and clinical trials of lead compound for nerve regeneration in 2021. With a unique nerve…
NervGen readies for NASDAQ listing and clinical trials of lead compound for nerve regeneration in 2021. With a unique nerve…
As we turn the page on 2014, here’s a list of some of the year’s highlights in neuroscience – along with a heavy dose of…
MedicalResearch.com Interview with: Bradley T. Lang, PhD Researcher, Jerry Silver Lab Department of Neurosciences Case Western…
The…
英国《自然》杂志4日报道说,动物实验显示,一种新药可使受伤脊柱中的
Case Western Reserve scientists developed a new chemical compound that shows extraordinary promise...
A new drug could partially relieve paralyzing spinal cord injuries, researchers report.
Jerry Silver (Case Western Reserve University) 4 December 2014. Researchers at Case Western Reserve University developed a…
Researchers at Case Western Reserve University in Ohio have developed a drug that helps rats with spinal injuries reclaim…
A Drug Might Heal Spinal Injuries By Sparking Nerve…
A neurologist's unorthodox thinking led to an experimental drug that allows trapped nerve fibers to grow again. And that growth…